Skip to main content

Mulroy Dennis's Form 4 filing

Anaptysbio, Inc (ANAB) · filed Sep 17, 2024

Accession no.
0001415889-24-023549
Filed
Sep 17, 2024
Trade date
Sep 14-16, 2024
Filing delay
3 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $487.7K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mulroy DennisCIK 0001276840Officer (CHIEF FINANCIAL OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 14, 2024Common StockMOption exerciseAcquired+6,000––6,964Direct
Sep 16, 2024Common StockSSaleDisposed−2,220$38.93−$86,424.64,744Direct
Sep 16, 2024Common StockMOption exerciseAcquired+10,000$20.16+$201,60014,744Direct
Sep 16, 2024Common StockSSaleDisposed−10,000$40.13−$401,3004,744Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 14, 2024Common StockMOption exerciseDisposed−6,000$0.00$00Direct
Sep 16, 2024Common StockMOption exerciseDisposed−10,000$0.00$080,600Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)